Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.82 |
| ▸ | EYA2 | O00167 | 1/20 | 0.82 |
| ▸ | APP | P05067 | 1/20 | 0.82 |
| ▸ | ACE | P12821 | 1/20 | 0.82 |
| ▸ | BLM | P54132 | 2/20 | 0.78 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.78 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.78 |
| ▸ | TSHR | P16473 | 2/20 | 0.78 |
| ▸ | LMNA | P02545 | 1/20 | 0.78 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.78 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.78 |
| ▸ | DRD1 | P21728 | 1/20 | 0.78 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.78 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.78 |
| ▸ | DRD3 | P35462 | 1/20 | 0.78 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.78 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edetic Acid SCHEMBL11477646 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL17477716 | 0.97 | TDP1 (0.88) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL8352896 | 0.94 | TDP1 (0.82) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL1832119 | 0.94 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL3735469 | 0.94 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL119008 | 0.94 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL394052 | 0.94 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL17097349 | 0.94 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL602070 | 0.94 | TDP1 (0.93) | TDP1EYA2APPACEBLM | |
| Edetic Acid SCHEMBL1079425 | 0.94 | TDP1 (0.93) | TDP1EYA2APPACEBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023109991-A1 | ANTIMICROBIAL PEPTIDES DERIVED FROM HUMAN AMELOBLASTIN PROTEIN, EFFECTIVE ON MICROBIAL BIOFILMS | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) | 2023-06-22 | — | — | WO | disclosed |
| EP-4178572-A1 | COMBINATION OF A METHIONINE AMINOPEPTIDASE 2 INHIBITOR AND VEGFR/VEGF INHIBITOR | Merck Patent GmbH (DE) | 2023-05-17 | — | — | EP | disclosed |
| US-20230072724-A1 | ARTICLES OF MANUFACTURE WITH DEGRADABLE DELIVERY PARTICLES BASED FROM AMINE CONTAINING NATURAL MATERIALS | ENCAPSYS, LLC (US) | 2023-03-09 | — | — | US | disclosed |
| EP-4103623-A1 | ARTICLES OF MANUFACTURE WITH POLYUREA CAPSULES CROSS-LINKED WITH CHITOSAN | Encapsys, LLC (US) | 2022-12-21 | — | — | EP | disclosed |
| EP-3390483-B1 | ENCAPSULATION | PROCTER & GAMBLE (US) | 2022-05-18 | — | — | EP | disclosed |
| WO-2022008469-A1 | COMBINATION OF A METHIONINE AMINOPEPTIDASE 2 INHIBITOR AND VEGFR/VEGF INHIBITOR | MERCK PATENT GMBH (DE) | 2022-01-13 | — | — | WO | disclosed |
| EP-3206782-B1 | CONTROLLED RELEASE DUAL WALLED MICROCAPSULES | PROCTER & GAMBLE (US) | 2021-12-15 | — | — | EP | disclosed |
| US-11180714-B2 | Controlled release microcapsules | ENCAPSYS, LLC (US) | 2021-11-23 | — | — | US | disclosed |
| US-20210339217-A1 | Articles of Manufacture with Polyurea Capsules Cross-linked with Chitosan | ENCAPSYS, LLC | 2021-11-04 | — | — | US | disclosed |
| WO-2021163599-A1 | ARTICLES OF MANUFACTURE WITH POLYUREA CAPSULES CROSS-LINKED WITH CHITOSAN | ENCAPSYS, LLC (US) | 2021-08-19 | — | — | WO | disclosed |
| EP-0530430-A1 | Process for treatment of aqueous solutions of polyhydric alcohols | FIRST BRANDS CORPORATION (US) | 1993-03-10 | — | — | EP | disclosed |
| EP-0476078-A4 | EXTRACTION AND RECOVERY OF GOLD | — | 1993-02-24 | — | — | EP | disclosed |
| EP-0476078-A1 | EXTRACTION AND RECOVERY OF GOLD. | CRA SERVICES (AU) | 1992-03-25 | — | — | EP | disclosed |
| WO-1991015591-A1 | DEGRADATION OF FERRIC CHELATES BY A PURE CULTURE OF $i(AGROBACTERIUM SP.) | GENENCOR INTERNATIONAL, INC. (US) | 1991-10-17 | — | — | WO | disclosed |
| WO-1991013177-A1 | EXTRACTION AND RECOVERY OF GOLD | CRA SERVICES LIMITED (AU) | 1991-09-05 | — | — | WO | disclosed |
| US-4810410-A | TRIVALENT COBALT AMMINE COMPLEXES | INTEROX CHEMICALS LIMITED (GB) | 1989-03-07 | — | — | US | disclosed |
| EP-0272030-A2 | Bleach activation | Interox Chemicals Limited (GB) | 1988-06-22 | — | — | EP | disclosed |
| US-4565880-A | ANTIFOULING | DENKA CHEMICAL CORPORATION (US) | 1986-01-21 | — | — | US | disclosed |
| US-4547305-A | CONTAINING A SILICATE AND TITANIUM | LEVER BROTHERS COMPANY (US) | 1985-10-15 | — | — | US | disclosed |
| US-3972992-A | Diagnostic test for opium alkaloids | HOFFMANN-LA ROCHE INC. (US) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11180714-B2 | Controlled release microcapsules | NSF, CRH, CHMP4B | TDP1 2893/4885EYA2 4337/4885APP 532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.